Relmada Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Relmada Therapeutics by Charles Schwab Investment Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $52k | 13k | 4.14 |
2023-09-30 | $38k | 13k | 3.00 |
2023-06-30 | $31k | 13k | 2.46 |
2023-03-31 | $167k | 74k | 2.26 |
2022-12-31 | $214k | 61k | 3.49 |
2022-09-30 | $2.6M | 71k | 37.03 |
2022-06-30 | $1.4M | 73k | 18.99 |
2022-03-31 | $1.8M | 67k | 27.00 |
2021-12-31 | $1.0M | 45k | 22.55 |
2021-09-30 | $1.1M | 41k | 26.23 |
2021-06-30 | $3.2M | 99k | 32.02 |
2021-03-31 | $3.3M | 95k | 35.22 |
2020-12-31 | $3.0M | 93k | 32.07 |
2020-09-30 | $3.4M | 89k | 37.62 |
2020-06-30 | $4.0M | 90k | 44.76 |
2020-03-31 | $1.8M | 53k | 34.13 |
2019-12-31 | $1.9M | 49k | 39.01 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management